SCHEMBL9955131

SCHEMBL9955131

COc1ncc(Br)cc1S(=O)(=O)Nc1cccc(OCCCNC(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FABP1 P07148 2/20 0.44
F2 P00734 3/20 0.43
ALPL P05186 4/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SHMT2 P34897 1/20 0.42
PIK3C3 Q8NEB9 1/20 0.42
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12474801 0.97 ALDH1A1 (0.45) FABP1F2ALPLALDH1A1SMN1; SMN2
SCHEMBL10289065 0.89 ITK (0.48) FABP1F2SHMT2PIK3C3MAPT
SCHEMBL9955800 0.87 ALPL (0.50) FABP1F2ALPLALDH1A1SMN1; SMN2
SCHEMBL12474952 0.84 ALPL (0.51) FABP1F2ALPLALDH1A1SMN1; SMN2
SCHEMBL790242 0.83 ALPL (0.58) FABP1F2ALPLALDH1A1SMN1; SMN2
SCHEMBL806765 0.83 LMNA (0.53) ALPLALDH1A1SMN1; SMN2SHMT2LMNA
SCHEMBL789685 0.80 ALPL (0.59) FABP1F2ALPLALDH1A1SMN1; SMN2
SCHEMBL9954777 0.78 PIK3CD (0.56) ALPLSHMT2MAPT
SCHEMBL9954165 0.76 PI4KA (0.65)
SCHEMBL806782 0.76 SMN1; SMN2 (0.54) ALPLALDH1A1SMN1; SMN2SHMT2PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed